You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Fool’s gold, lost treasures, and the randomized clinical trial
|
|---|---|
| Published in |
BMC Cancer, April 2013
|
| DOI | 10.1186/1471-2407-13-193 |
| Pubmed ID | |
| Authors |
David J Stewart, Razelle Kurzrock |
| Abstract |
Randomized controlled trials with a survival endpoint are the gold standard for clinical research, but have failed to achieve cures for most advanced malignancies. The high costs of randomized clinical trials slow progress (thereby causing avoidable loss of life) and increase health care costs. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 67% |
| United Kingdom | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 67% |
| Practitioners (doctors, other healthcare professionals) | 2 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Ecuador | 2 | 2% |
| United States | 2 | 2% |
| Uruguay | 1 | 1% |
| China | 1 | 1% |
| Netherlands | 1 | 1% |
| Unknown | 76 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 25% |
| Student > Ph. D. Student | 14 | 17% |
| Student > Bachelor | 9 | 11% |
| Other | 9 | 11% |
| Student > Master | 8 | 10% |
| Other | 16 | 19% |
| Unknown | 6 | 7% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 37 | 45% |
| Agricultural and Biological Sciences | 8 | 10% |
| Biochemistry, Genetics and Molecular Biology | 7 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
| Nursing and Health Professions | 3 | 4% |
| Other | 12 | 14% |
| Unknown | 11 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2018.
All research outputs
#2,850,745
of 25,654,806 outputs
Outputs from BMC Cancer
#548
of 9,034 outputs
Outputs of similar age
#21,943
of 195,196 outputs
Outputs of similar age from BMC Cancer
#4
of 106 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,034 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,196 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.